Summary
Although progress is being made in the development of new clinical treatments for traumatic brain injury (TBI), little is known about whether such treatments are effective in older patients, in whom frailty, prior medical conditions, altered metabolism, and changing sensitivity to medications all can affect outcomes following a brain injury. In this review we consider TBI to be a complex, highly variable, and systemic disorder that may require a new pharmacotherapeutic approach, one using combinations or cocktails of drugs to treat the many components of the injury cascade. We review some recent research on the role of vitamin D hormone and vitamin D deficiency in older subjects, and on the interactions of these factors with progesterone, the only treatment for TBI that has shown clinical effectiveness. Progesterone is now in phase III multicenter trial testing in the United States. We also discuss some of the potential mechanisms and pathways through which the combination of hormones may work, singly and in synergy, to enhance survival and recovery after TBI.
Key Words: Traumatic brain injury, aging, frailty, progesterone, vitamin D, morphological and functional recovery, systems
References
- 1.Schumacher M, Guennoun R, Stein DG, De Nicola AF. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther. 2007;116:77–107. doi: 10.1016/j.pharmthera.2007.06.001. [DOI] [PubMed] [Google Scholar]
- 2.Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil. 1999;14:602–615. doi: 10.1097/00001199-199912000-00009. [DOI] [PubMed] [Google Scholar]
- 3.Povlishock JT, Katz DI. Update of neuropathology and neurological recovery after traumatic brain injury. J Head Trauma Rehabil. 2005;20:76–94. doi: 10.1097/00001199-200501000-00008. [DOI] [PubMed] [Google Scholar]
- 4.Vink R, Nimmo AJ. Multifunctional drugs for head injury. Neurotherapeutics. 2009;6:28–42. doi: 10.1016/j.nurt.2008.10.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Margulies S, Hicks R, Combination Therapies for Traumatic Brain Injury Workshop Leaders Combination therapies for traumatic brain injury: prospective considerations. J Neurotrauma. 2009;26:925–939. doi: 10.1089/neu.2008.0794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Narayan RK, Michel ME, Ansell B, et al. Clinical trials in head injury. J Neurotrauma. 2002;19:503–557. doi: 10.1089/089771502753754037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zygun DA, Kortbeek JB, Fick GH, Laupland KB, Doig CJ. Non-neurologic organ dysfunction in severe traumatic brain injury. Crit Care Med. 2005;33:654–660. doi: 10.1097/01.CCM.0000155911.01844.54. [DOI] [PubMed] [Google Scholar]
- 8.Harwood PJ, Giannoudis PV, van Griensven M, Krettek C, Pape HC. Alterations in the systemic inflammatory response after early total care and damage control procedures for femoral shaft fracture in severely injured patients. J Trauma. 2005;58:446–452. doi: 10.1097/01.TA.0000153942.28015.77. [DOI] [PubMed] [Google Scholar]
- 9.Pape HC, Tsukamoto T, Kobbe P, Tarkin I, Katsoulis S, Peitzman A. Assessment of the clinical course with inflammatory parameters. Injury. 2007;38:1358–1364. doi: 10.1016/j.injury.2007.09.026. [DOI] [PubMed] [Google Scholar]
- 10.Keel M, Trente O. Pathophysiology of polytrauma. Injury. 2005;36:691–709. doi: 10.1016/j.injury.2004.12.037. [DOI] [PubMed] [Google Scholar]
- 11.Zygun D. Non-neurological organ dysfunction in neurocritical care: impact on outcome and etiological considerations. Curr Opin Crit Care. 2005;11:139–143. doi: 10.1097/01.ccx.0000155356.86241.c0. [DOI] [PubMed] [Google Scholar]
- 12.Shohami E, Gati I, Beit-Yannai E, Trembovler V, Kohen R. Closed head injury in the rat induces whole body oxidative stress: overall reducing antioxidant profile. J Neurotrauma. 1999;16:365–376. doi: 10.1089/neu.1999.16.365. [DOI] [PubMed] [Google Scholar]
- 13.Moinard C, Gupta S, Besson V, et al. Evidence for impairment of hepatic energy homeostasis in head-injured rat. J Neurotrauma. 2008;25:124–129. doi: 10.1089/neu.2007.0391. [DOI] [PubMed] [Google Scholar]
- 14.Bochicchio GV, Napolitano LM, Joshi M, McCarter RJ, Scalea TM. Systemic inflammatory response syndrome score at admission independently predicts infection in blunt trauma patients. J Trauma. 2001;50:817–820. doi: 10.1097/00005373-200105000-00007. [DOI] [PubMed] [Google Scholar]
- 15.Malone DL, Kuhls D, Napolitano LM, McCarter R, Scalea T. Back to basics: validation of the admission systemic inflammatory response syndrome score in predicting outcome in trauma. J Trauma. 2001;51:458–463. doi: 10.1097/00005373-200109000-00006. [DOI] [PubMed] [Google Scholar]
- 16.Napolitano LM, Ferrer T, McCarter RJ, Scalea TM. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. J Trauma. 2000;49:647–652. doi: 10.1097/00005373-200010000-00011. [DOI] [PubMed] [Google Scholar]
- 17.Nast-Kolb D, Waydhas C, Gippner-Steppert C, et al. Indicators of the posttraumatic inflammatory response correlate with organ failure in patients with multiple injuries. J Trauma. 1997;42:446–454. doi: 10.1097/00005373-199703000-00012. [DOI] [PubMed] [Google Scholar]
- 18.Nuytinck HK, Offermans XJ, Kubat K, Goris JA. Whole-body inflammation in trauma patients: an autopsy study. Arch Surg. 1988;123:1519–1524. doi: 10.1001/archsurg.1988.01400360089016. [DOI] [PubMed] [Google Scholar]
- 19.Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–454. doi: 10.1056/NEJM199902113400607. [DOI] [PubMed] [Google Scholar]
- 20.Gebhard F, Pfetsch H, Steinbach G, Strecker W, Kinzl L, Brückner UB. Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg. 2000;135:291–295. doi: 10.1001/archsurg.135.3.291. [DOI] [PubMed] [Google Scholar]
- 21.Vodovotz Y, Csete M, Bartels J, Chang S, An G. Translational systems biology of inflammation. PLoS Comput Biol. 2008;4:1–6. doi: 10.1371/journal.pcbi.1000014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Frink M, Pape HC, van Griensven M, Krettek C, Chaudry IH, Hildebrand F. Influence of sex and age on MODS and cytokines after multiple injuries. Shock. 2007;27:151–156. doi: 10.1097/01.shk.0000239767.64786.de. [DOI] [PubMed] [Google Scholar]
- 23.Attella MJ, Nattinville A, Stein DG. Hormonal state affects recovery from frontal cortex lesions in adult female rats. Behav Neural Biol. 1987;48:352–367. doi: 10.1016/S0163-1047(87)90918-6. [DOI] [PubMed] [Google Scholar]
- 24.Roof RL, Stein DG. Progesterone treatment attenuates brain edema following contusion injury in male and female rats. Restor Neurol Neurosci. 1992;4:425–427. doi: 10.3233/RNN-1992-4608. [DOI] [PubMed] [Google Scholar]
- 25.Goss CW, Hoffman SW, Stein DG. Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study. Pharmacol Biochem Behav. 2003;76:231–242. doi: 10.1016/j.pbb.2003.07.003. [DOI] [PubMed] [Google Scholar]
- 26.Djebaili M, Guo Q, Pettus EH, Hoffman SW, Stein DG. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma. 2005;22:106–118. doi: 10.1089/neu.2005.22.106. [DOI] [PubMed] [Google Scholar]
- 27.Pettus EH, Wright DW, Stein DG, Hoffman SW. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res. 2005;1049:112–119. doi: 10.1016/j.brainres.2005.05.004. [DOI] [PubMed] [Google Scholar]
- 28.Djebaili M, Hoffman SW, Stein DG. Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience. 2004;123:349–359. doi: 10.1016/j.neuroscience.2003.09.023. [DOI] [PubMed] [Google Scholar]
- 29.Stein DG. Progesterone exerts neuroprotective effects after brain injury. Brain Res Rev. 2008;57:386–397. doi: 10.1016/j.brainresrev.2007.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Guo Q, Baronne L, Hoffman SW, Guennoun R, Stein DG. Progesterone’s effects on aquaporin-4 expression after traumatic brain injury in male rats. J Neurotrauma. 2004;21:1303–1303. [Google Scholar]
- 31.Shear DA, Galani R, Hoffman SW, Stein DG. Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Exp Neurol. 2002;178:59–67. doi: 10.1006/exnr.2002.8020. [DOI] [PubMed] [Google Scholar]
- 32.McCullough LD, Hum PD. Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol Metab. 2003;14:228–235. doi: 10.1016/S1043-2760(03)00076-6. [DOI] [PubMed] [Google Scholar]
- 33.Stein DG. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? Trends Neurosci. 2001;24:386–391. doi: 10.1016/S0166-2236(00)01821-X. [DOI] [PubMed] [Google Scholar]
- 34.Stein DG, Hoffman SW. Concepts of CNS plasticity in the context of brain damage and repair. J Head Trauma Rehabil. 2003;18:317–341. doi: 10.1097/00001199-200307000-00004. [DOI] [PubMed] [Google Scholar]
- 35.Stein DG, Hoffman SW. Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr Rehabil. 2003;6:13–22. doi: 10.1080/1363849031000095279. [DOI] [PubMed] [Google Scholar]
- 36.Schumacher M, Guennoun R, Ghoumari A, et al. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr Rev. 2007;28:387–439. doi: 10.1210/er.2006-0050. [DOI] [PubMed] [Google Scholar]
- 37.Guo Q, Sayeed I, Baronne LM, Hoffman SW, Guennoun R, Stein DG. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp Neurol. 2006;198:469–478. doi: 10.1016/j.expneurol.2005.12.013. [DOI] [PubMed] [Google Scholar]
- 38.Sayeed I, Guo Q, Hoffman SW, Stein DG. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann Emerg Med. 2006;47:381–389. doi: 10.1016/j.annemergmed.2005.12.011. [DOI] [PubMed] [Google Scholar]
- 39.Wright DW, Kellermann AL, Hertzberg VS, et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med. 2007;49:391–402. doi: 10.1016/j.annemergmed.2006.07.932. [DOI] [PubMed] [Google Scholar]
- 40.Xiao G, Wei J, Yan W, Wang W, Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care. 2008;12:R61–R61. doi: 10.1186/cc6887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Chen G, Shi JX, Qi M, Wang HX, Hang CH. Effects of progesterone on intestinal inflammatory response, mucosa structure alterations, and apoptosis following traumatic brain injury in male rats. J Surg Res. 2008;147:92–98. doi: 10.1016/j.jss.2007.05.029. [DOI] [PubMed] [Google Scholar]
- 42.Adekoya N, Thurman DJ, White DD, Webb KW. Surveillance for traumatic brain injury deaths: United States, 1989–1998. MMWR Surveill Summ. 2002;51:1–14. [PubMed] [Google Scholar]
- 43.Mosenthal AC, Lavery RF, Addis M, et al. Isolated traumatic brain injury: age is an independent predictor of mortality and early outcome. J Trauma. 2002;52:907–911. doi: 10.1097/00005373-200205000-00015. [DOI] [PubMed] [Google Scholar]
- 44.McArthur DL, Chute DJ, Villablanca JP. Moderate and severe traumatic brain injury: epidemiologic, imaging and neuropathologic perspectives. Brain Pathol. 2004;14:185–194. doi: 10.1111/j.1750-3639.2004.tb00052.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Gomez PA, Lobato RD, Boto GR, De la Lama A, Gonzalez PJ, de la Cruz J. Age and outcome after severe head injury. Acta Neurochir (Wien) 2000;142:373–380. doi: 10.1007/s007010050445. [DOI] [PubMed] [Google Scholar]
- 46.Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male. 2002;5:98–102. [PubMed] [Google Scholar]
- 47.Vermeulen A, Kaufman JM. Ageing of the hypothalamo-pituitary-testicular axis in men. Horm Res. 1995;43:25–28. doi: 10.1159/000184233. [DOI] [PubMed] [Google Scholar]
- 48.Lanfranco F, Gianotti L, Giordano R, Pellegrino M, Maccario M, Arvat E. Ageing, growth hormone and physical performance. J Endocrinol Invest. 2003;26:861–872. doi: 10.1007/BF03345237. [DOI] [PubMed] [Google Scholar]
- 49.Araujo AB, O’Donnell AB, Brambilla DJ, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004;89:5920–5926. doi: 10.1210/jc.2003-031719. [DOI] [PubMed] [Google Scholar]
- 50.Rammos G, Tseke P, Ziakka S. Vitamin D, the renin-angiotensin system, and insulin resistance. Int Urol Nephrol. 2008;40:419–426. doi: 10.1007/s11255-007-9244-4. [DOI] [PubMed] [Google Scholar]
- 51.Vasto S, Candore G, Balistreri CR, et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev. 2007;128:83–91. doi: 10.1016/j.mad.2006.11.015. [DOI] [PubMed] [Google Scholar]
- 52.Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. 2007;211:144–156. doi: 10.1002/path.2104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Bulati M, Pellicanò M, Vasto S, Colonna-Romano G. Understanding ageing: biomedical and bioengineering approaches, the immunologic view. Immun Ageing. 2008;5:9–9. doi: 10.1186/1742-4933-5-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128:92–105. doi: 10.1016/j.mad.2006.11.016. [DOI] [PubMed] [Google Scholar]
- 55.Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54:991–1001. doi: 10.1111/j.1532-5415.2006.00745.x. [DOI] [PubMed] [Google Scholar]
- 56.Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–M156. doi: 10.1093/gerona/56.3.M146. [DOI] [PubMed] [Google Scholar]
- 57.Hof PR, Morrison JH. The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci. 2004;27:607–613. doi: 10.1016/j.tins.2004.07.013. [DOI] [PubMed] [Google Scholar]
- 58.Dickstein DL, Kabaso D, Rocher AB, Luebke JI, Wearne SL, Hof PR. Changes in the structural complexity of the aged brain. Aging Cell. 2007;6:275–284. doi: 10.1111/j.1474-9726.2007.00289.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Mattson MP, Magnus T. Ageing and neuronal vulnerability. Nat Rev Neurosci. 2006;7:278–294. doi: 10.1038/nrn1886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Mattson MP. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med. 2003;3:65–94. doi: 10.1385/NMM:3:2:65. [DOI] [PubMed] [Google Scholar]
- 61.Melov S. Modeling mitochondrial function in aging neurons. Trends Neurosci. 2004;27:601–606. doi: 10.1016/j.tins.2004.08.004. [DOI] [PubMed] [Google Scholar]
- 62.Godbout JP, Chen J, Abraham J, et al. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 2005;19:1329–1331. doi: 10.1096/fj.05-3776fje. [DOI] [PubMed] [Google Scholar]
- 63.Frank MG, Barrientos RM, Biedenkapp JC, Rudy JW, Watkins LR, Maier SF. mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging. Neurobiol Aging. 2006;27:717–722. doi: 10.1016/j.neurobiolaging.2005.03.013. [DOI] [PubMed] [Google Scholar]
- 64.Perry VH, Matyszak MK, Feam S. Altered antigen expression of microglia in the aged rodent CNS. Glia. 1993;7:60–67. doi: 10.1002/glia.440070111. [DOI] [PubMed] [Google Scholar]
- 65.Sheffield LG, Berman NE. Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol Aging. 1998;19:47–55. doi: 10.1016/S0197-4580(97)00168-1. [DOI] [PubMed] [Google Scholar]
- 66.Godbout JP, Johnson RW. Age and neuroinflammation: a lifetime of psychoneuroimmune consequences. Neurol Clin. 2006;24:521–538. doi: 10.1016/j.ncl.2006.03.010. [DOI] [PubMed] [Google Scholar]
- 67.Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury. 2007;38:1336–1345. doi: 10.1016/j.injury.2007.10.003. [DOI] [PubMed] [Google Scholar]
- 68.Dilger RN, Johnson RW. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J Leukoc Biol. 2008;84:932–939. doi: 10.1189/jlb.0208108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Griffin R, Nally R, Nolan Y, McCartney Y, Linden J, Lynch MA. The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem. 2006;99:1263–1272. doi: 10.1111/j.1471-4159.2006.04165.x. [DOI] [PubMed] [Google Scholar]
- 70.Li AJ, Katafuchi T, Oda S, Hori T, Oomura Y. Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res. 1997;748:30–38. doi: 10.1016/S0006-8993(96)01283-8. [DOI] [PubMed] [Google Scholar]
- 71.Vereker E, O’Donnell E, Lynch MA. The inhibitory effect of interleukin-1β on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J Neurosci. 2000;20:6811–6819. doi: 10.1523/JNEUROSCI.20-18-06811.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Barrientos RM, Higgins EA, Biedenkapp JC, et al. Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol Aging. 2006;27:723–732. doi: 10.1016/j.neurobiolaging.2005.03.010. [DOI] [PubMed] [Google Scholar]
- 73.Neumann H, Schweigreiter R, Yamashita T, Rosenkranz K, Wekerle H, Barde YA. Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J Neurosci. 2002;22:854–862. doi: 10.1523/JNEUROSCI.22-03-00854.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Vallières L, Campbell IL, Gage FH, Sawchenko PE. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci. 2002;22:486–492. doi: 10.1523/JNEUROSCI.22-02-00486.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Straub RH, Miller LE, Schölmerich J, Zietz B. Cytokines and hormones as possible links between endocrinosenescence and immunosenescence. J Neuroimmunol. 2000;109:10–15. doi: 10.1016/S0165-5728(00)00296-4. [DOI] [PubMed] [Google Scholar]
- 76.Jiang M, Huhtaniemi I. Polymorphisms in androgen and estrogen receptor genes: effects on male aging. Exp Gerontol. 2004;39:1603–1611. doi: 10.1016/j.exger.2004.06.017. [DOI] [PubMed] [Google Scholar]
- 77.Elmadfa I, Meyer AL. Body composition, changing physiological functions and nutrient requirements of the elderly. Ann Nutr Metab. 2008;52(Suppl 1):2–5. doi: 10.1159/000115339. [DOI] [PubMed] [Google Scholar]
- 78.Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nute. 2004;80(6):1678S–1688S. doi: 10.1093/ajcn/80.6.1678S. [DOI] [PubMed] [Google Scholar]
- 79.Ferrucci L, Ble A, Bandinelli S, Lauretani F, Suthers K, Guralnik JM. A flame burning within. Aging Clin Exp Res. 2004;16:240–243. doi: 10.1007/BF03327390. [DOI] [PubMed] [Google Scholar]
- 80.Talhouk RS, Saadé NE, Mouneimne G, Masaad CA, Safieh-Garabedian B. Growth hormone releasing hormone reverses endotoxin-induced localized inflammatory hyperalgesia without reducing the upregulated cytokines, nerve growth factor and gelatinase activity. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:625–631. doi: 10.1016/j.pnpbp.2004.01.012. [DOI] [PubMed] [Google Scholar]
- 81.Priego T, Granado M, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A. Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats. J Endocrinol. 2003;179:107–117. doi: 10.1677/joe.0.1790107. [DOI] [PubMed] [Google Scholar]
- 82.Beishuizen A, Thijs LG. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res. 2003;9:3–24. doi: 10.1179/096805103125001298. [DOI] [PubMed] [Google Scholar]
- 83.Topinkova E. Aging, disability and frailty. Ann Nutr Metab. 2008;52(Suppl 1):6–11. doi: 10.1159/000115340. [DOI] [PubMed] [Google Scholar]
- 84.Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662–687. doi: 10.1210/er.2004-0002. [DOI] [PubMed] [Google Scholar]
- 85.Richards JB, Valdes AM, Gardner JP, et al. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nute. 2007;86:1420–1425. doi: 10.1093/ajcn/86.5.1420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Moore ME, Piazza A, McCartney Y, Lynch MA. Evidence that vitamin D3 reverses age-related inflammatory changes in the rat hippocampus. Biochem Soc Trans. 2005;33:573–577. doi: 10.1042/BST0330573. [DOI] [PubMed] [Google Scholar]
- 87.Boxer RS, Dauser DA, Walsh SJ, Hager WD, Kenny AM. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc. 2008;56:454–461. doi: 10.1111/j.1532-5415.2007.01601.x. [DOI] [PubMed] [Google Scholar]
- 88.Morley JE, Haren MT, Rolland Y, Kim MJ. Frailty. Med Clin North Am. 2006;90:837–847. doi: 10.1016/j.mcna.2006.05.019. [DOI] [PubMed] [Google Scholar]
- 89.Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281. doi: 10.1056/NEJMra070553. [DOI] [PubMed] [Google Scholar]
- 90.Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living healthy young adults. Am J Med. 2002;112:659–662. doi: 10.1016/S0002-9343(02)01091-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med. 2004;158:531–537. doi: 10.1001/archpedi.158.6.531. [DOI] [PubMed] [Google Scholar]
- 92.Nadziejko C, Fang K, Narciso S, et al. Effect of particulate and gaseous pollutants on spontaneous arrhythmias in aged rats. Inhal Toxicol. 2004;16:373–380. doi: 10.1080/08958370490439533. [DOI] [PubMed] [Google Scholar]
- 93.Sullivan SS, Rosen CJ, Halteman WA, Chen TC, Holick MF. Adolescent girls in Maine are at risk for vitamin D insufficiency. J Am Diet Assoc. 2005;105:971–974. doi: 10.1016/j.jada.2005.03.002. [DOI] [PubMed] [Google Scholar]
- 94.Chatfield SM, Brand C, Ebeling PR, Russell DM. Vitamin D deficiency in general medical inpatients in summer and winter. Intern Med J. 2007;37:377–382. doi: 10.1111/j.1445-5994.2007.01339.x. [DOI] [PubMed] [Google Scholar]
- 95.Corino A, D’Amelio P, Gancia R, et al. Hypovitaminosis D in internal medicine inpatients. Calcif Tissue Int. 2007;80:76–80. doi: 10.1007/s00223-006-0189-x. [DOI] [PubMed] [Google Scholar]
- 96.Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience. 2003;118:641–653. doi: 10.1016/S0306-4522(03)00040-X. [DOI] [PubMed] [Google Scholar]
- 97.Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 α-hydroxylase in human brain. J Chem Neuroanat. 2005;29:21–30. doi: 10.1016/j.jchemneu.2004.08.006. [DOI] [PubMed] [Google Scholar]
- 98.Hewison M, Zehnder D, Bland R, Stewart PM. 1α-Hydroxylase and the action of vitamin D. J Mol Endocrinol. 2000;25:141–148. doi: 10.1677/jme.0.0250141. [DOI] [PubMed] [Google Scholar]
- 99.Holick MF. McCollum Award Lecture, 1994. Vitamin D: new horizons for the 21st century. Am J Clin Nutr. 1994;60:619–630. doi: 10.1093/ajcn/60.4.619. [DOI] [PubMed] [Google Scholar]
- 100.Larrosa M, Gratacòs J, Vaqueiro M, Prat M, Campos F, Roqué M. Prevalence of hypovitaminosis D in elderly institutionalized residents: influence of a substitutive treatment [In Spanish] Med Clin (Barc) 2001;117:611–614. doi: 10.1016/s0025-7753(01)72195-1. [DOI] [PubMed] [Google Scholar]
- 101.McGrath JJ, Féron FP, Bume TH, Mackay-Sim A, Eyles DW. Vitamin D3: implications for brain development. J Steroid Biochem Mol Biol. 2004;89-90:557–560. doi: 10.1016/j.jsbmb.2004.03.070. [DOI] [PubMed] [Google Scholar]
- 102.Townsend K, Evans KN, Campbell MJ, Colston KW, Adams JS, Hewison M. Biological actions of extra-renal 25-hydroxyvitamin D-1α-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol. 2005;97:103–109. doi: 10.1016/j.jsbmb.2005.06.004. [DOI] [PubMed] [Google Scholar]
- 103.Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 2003;49:277–300. [PubMed] [Google Scholar]
- 104.DeLuca HF, Zierold C. Mechanisms and functions of vitamin D. Nutr Rev. 1998;56:S4–S10. doi: 10.1111/j.1753-4887.1998.tb01686.x. [DOI] [PubMed] [Google Scholar]
- 105.Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003;23:117–145. doi: 10.1146/annurev.nutr.23.011702.073114. [DOI] [PubMed] [Google Scholar]
- 106.Cantoma MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80:1717S–1720S. doi: 10.1093/ajcn/80.6.1717S. [DOI] [PubMed] [Google Scholar]
- 107.Mahon BD, Wittke A, Weaver V, Cantoma MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem. 2003;89:922–932. doi: 10.1002/jcb.10580. [DOI] [PubMed] [Google Scholar]
- 108.Holick MF. Evolution and function of vitamin D. Recent Results Cancer Res. 2003;164:3–28. doi: 10.1007/978-3-642-55580-0_1. [DOI] [PubMed] [Google Scholar]
- 109.Holick MF. Vitamin D: a millenium perspective. J Cell Biochem. 2003;88:296–307. doi: 10.1002/jcb.10338. [DOI] [PubMed] [Google Scholar]
- 110.Melamed ML, Muntner P, Michos ED, et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol. 2008;28:1179–1185. doi: 10.1161/ATVBAHA.108.165886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167:1159–1165. doi: 10.1001/archinte.167.11.1159. [DOI] [PubMed] [Google Scholar]
- 112.Onyszchuk G, He YY, Berman NE, Brooks WM. Detrimental effects of aging on outcome from traumatic brain injury: a behavioral, magnetic resonance imaging, and histological study in mice. J Neurotrauma. 2008;25:153–171. doi: 10.1089/neu.2007.0430. [DOI] [PubMed] [Google Scholar]
- 113.Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int. 2002;13:187–194. doi: 10.1007/s001980200012. [DOI] [PubMed] [Google Scholar]
- 114.Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005;35:290–304. doi: 10.1111/j.1365-2362.2005.01487.x. [DOI] [PubMed] [Google Scholar]
- 115.Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13:100–105. doi: 10.1016/S1043-2760(01)00547-1. [DOI] [PubMed] [Google Scholar]
- 116.Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport. 2004;15:1271–1274. doi: 10.1097/01.wnr.0000129370.04248.92. [DOI] [PubMed] [Google Scholar]
- 117.Dawson-Hughes B. Serum 25-hydroxyvitamin D and functional outcomes in the elderly. Am J Clin Nute. 2008;88:537S–540S. doi: 10.1093/ajcn/88.2.537S. [DOI] [PubMed] [Google Scholar]
- 118.McCarty MF. Secondary hyperparathyroidism promotes the acute phase response: a rationale for supplemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses. 2005;64:1022–1026. doi: 10.1016/j.mehy.2004.03.041. [DOI] [PubMed] [Google Scholar]
- 119.Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8–F28. doi: 10.1152/ajprenal.00336.2004. [DOI] [PubMed] [Google Scholar]
- 120.van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97:93–101. doi: 10.1016/j.jsbmb.2005.06.002. [DOI] [PubMed] [Google Scholar]
- 121.Cutler SM, Cekic M, Miller DM, Wali B, VanLandingham JW, Stein DG. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J Neurotrauma. 2007;24:1475–1486. doi: 10.1089/neu.2007.0294. [DOI] [PubMed] [Google Scholar]
- 122.Bauer B, Hartz AM, Flicker G, Miller DS. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol. 2004;66:413–419. doi: 10.1124/mol.66.3.. [DOI] [PubMed] [Google Scholar]
- 123.Miller DS, Bauer B, Hartz AM. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev. 2008;60:196–209. doi: 10.1124/pr.107.07109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Langmade SJ, Gale SE, Frolov A, et al. Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc Natl Acad Sci U S A. 2006;103:13807–13812. doi: 10.1073/pnas.0606218103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Cekic M, Cutler SM, Vanlandingham JW, Stein DG. Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats. Neurobiol Aging 2009 May 29 [Epub ahead of print]. [DOI] [PMC free article] [PubMed]
- 126.Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92:4–8. doi: 10.1016/j.pbiomolbio.2006.02.016. [DOI] [PubMed] [Google Scholar]
- 127.Miller RR, Hicks GE, Shardell MD, et al. Association of serum vitamin D levels with inflammatory response following hip fracture: the Baltimore Hip Studies. J Gerontol A Biol Sci Med Sci. 2007;62:1402–1406. doi: 10.1093/gerona/62.12.1402. [DOI] [PubMed] [Google Scholar]
- 128.Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab. 2003;88:4623–4632. doi: 10.1210/jc.2003-030358. [DOI] [PubMed] [Google Scholar]
- 129.Powner DJ, Boccalandro C, Alp MS, Vollmer DG. Endocrine failure after traumatic brain injury in adults. Neurocrit Care. 2006;5:61–70. doi: 10.1385/NCC:5:1:61. [DOI] [PubMed] [Google Scholar]
- 130.Faden AI. Neuroprotection and traumatic brain injury: the search continues. Arch Neurol. 2001;58:1553–1555. doi: 10.1001/archneur.58.10.1553. [DOI] [PubMed] [Google Scholar]
- 131.Gingrich MB, Traynelis SF. Serine proteases and brain damage: is there a link? Trends Neurosci. 2000;23:399–407. doi: 10.1016/S0166-2236(00)01617-9. [DOI] [PubMed] [Google Scholar]
- 132.Brinton RD, Thompson RF, Foy MR, et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol. 2008;29:313–339. doi: 10.1016/j.yfrne.2008.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Chatterjee M. Vitamin D and genomic stability. Mutat Res. 2001;475:69–87. doi: 10.1016/S0027-5107(01)00080-X. [DOI] [PubMed] [Google Scholar]
- 134.Cozzolino M, Lu Y, Finch J, Slatopolsky E, Dusso AS. p21WAFl and TGF-α mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int. 2001;60:2109–2117. doi: 10.1046/j.1523-1755.2001.00042.x. [DOI] [PubMed] [Google Scholar]
- 135.Jensen SS, Madsen MW, Lukas J, Binderup L, Bartek J. Inhibitory effects of 1α,25-dihydroxyvitamin D3 on the G1-S phase-controlling machinery. Mol Endocrinol. 2001;15:1370–1380. doi: 10.1210/me.15.8.1370. [DOI] [PubMed] [Google Scholar]
- 136.Cemak I, Stoica B, Byrnes KR, Di Giovanni S, Faden AI. Role of the cell cycle in the pathobiology of central nervous system trauma. Cell Cycle. 2005;4:1286–1293. doi: 10.4161/cc.4.9.1996. [DOI] [PubMed] [Google Scholar]
- 137.Di Giovanni S, Movsesyan V, Ahmed F, et al. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci U S A. 2005;102:8333–8338. doi: 10.1073/pnas.0500989102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138.Brown J, Bianco JI, McGrath JJ, Eyles DW. 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett. 2003;343:139–143. doi: 10.1016/S0304-3940(03)00303-3. [DOI] [PubMed] [Google Scholar]
- 139.Wion D, MacGrogan D, Neveu I, Jehan F, Houlgatte R, Brachet P. 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res. 1991;28:110–114. doi: 10.1002/jnr.490280111. [DOI] [PubMed] [Google Scholar]
- 140.Atif F, Sayeed I, Ishrat T, Stein DG. Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol Med. 2009;15:328–336. doi: 10.2119/molmed.2009.00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Stein DG, Wright DW, Kellermann AL. Does progesterone have neuroprotective properties? Ann Emerg Med. 2008;51:164–172. doi: 10.1016/j.annemergmed.2007.05.001. [DOI] [PubMed] [Google Scholar]
- 142.Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altem Med Rev. 2003;8:223–246. [PubMed] [Google Scholar]
- 143.Paganelli R, Di Iorio A, Cherubini A, et al. Frailty of older age: the role of the endocrine-immune interaction. Curr Pharm Des. 2006;12:3147–3159. doi: 10.2174/138161206777947533. [DOI] [PubMed] [Google Scholar]
- 144.Lipsitz LA. Physiological complexity, aging, and the path to frailty. Sci Aging Knowledge Environ. 2004;2004:pe16–pe16. doi: 10.1126/sageke.2004.16.pe16. [DOI] [PubMed] [Google Scholar]
- 145.Lipsitz LA, Goldberger AL. Loss of ‘complexity’ and aging: potential applications of fractals and chaos theory to senescence. JAMA. 1992;267:1806–1809. doi: 10.1001/jama.267.13.1806. [DOI] [PubMed] [Google Scholar]
- 146.Goldberger AL, Peng CK, Lipsitz LA. What is physiologic complexity and how does it change with aging and disease? Neurobiol Aging. 2002;23:23–26. doi: 10.1016/S0197-4580(01)00266-4. [DOI] [PubMed] [Google Scholar]
- 147.Schulte-Frohlinde V, Ashkenazy Y, Goldberger AL, et al. Complex patterns of abnormal heartbeats. Phys Rev E Stat Nonlin Soft Matter Phys. 2002;66(3):031901–031901. doi: 10.1103/PhysRevE.66.031901. [DOI] [PubMed] [Google Scholar]
- 148.Costa M, Goldberger AL. Multiscale entropy analysis of complex physiologic time series. Phys Rev Lett. 2002;89(6):068102–068102. doi: 10.1103/PhysRevLett.89.068102. [DOI] [PubMed] [Google Scholar]
- 149.Hausdorff JM, Peng CK, Goldberger AL, Stoll AL. Gait unsteadiness and fall risk in two affective disorders: a preliminary study. BMC Psychiatry. 2004;4:39–39. doi: 10.1186/1471-244X-4-39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Novak V, Yang AC, Lepicovsky L, Goldberger AL, Lipsitz LA, Peng CK. Multimodal pressure-flow method to assess dynamics of cerebral autoregulation in stroke and hypertension. Biomed Eng Online. 2004;3:39–39. doi: 10.1186/1475-925X-3-39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Andrews-Hanna JR, Snyder AZ, Vincent JL, et al. Disruption of large-scale brain systems in advanced aging. Neuron. 2007;56:924–935. doi: 10.1016/j.neuron.2007.10.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152.Villoslada P, Steinman L, Baranzini SE. Systems biology and its application to the understanding of neurological diseases. Ann Neurol. 2009;65:124–139. doi: 10.1002/ana.21634. [DOI] [PubMed] [Google Scholar]
- 153.Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008;4:404–412. doi: 10.1038/ncprheum0855. [DOI] [PubMed] [Google Scholar]